Rubicon Research IPO Listing Preview: What to Expect Now?
- October 14, 2025
- Posted by: sachet
- Category: IPO
Click to check Rubicon Research IPO GMP Live.
The Rubicon Research IPO listing is scheduled for 16th October 2025. The IPO was open for bidding from 9th October 2025 to 13th October 2025. It is a book-building IPO of ₹1,377.50 crore, comprising an entirely fresh issue of 1.03 crore shares. The issue will be listed on the BSE and NSE on its tentative listing date, 16th October 2025. Scroll down to learn more about Rubicon Research’s IPO listing expectations.
Rubicon Research IPO Listing Preview
According to recent updates, the IPO listing of Rubicon Research is expected to be around ₹615 per share on 16th October 2025. This conclusion is based on Rubicon Research’s current IPO GMP (grey market premium). However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to receive live updates on current IPO listings or GMP trends. Scroll to explore the GMP of the Rubicon Research IPO.
Rubicon Research IPO GMP Grey Market Premium
GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to receive live updates on the Rubicon Research IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 14-10-2025 | ₹485.00 | ₹130.00 | ₹615.00 | 26.80% |
| 13-10-2025 | ₹485.00 | ₹127.00 | ₹612.00 | 26.19% |
| 12-10-2025 | ₹485.00 | ₹96.00 | ₹581.00 | 19.79% |
| 11-10-2025 | ₹485.00 | ₹96.00 | ₹581.00 | 19.79% |
| 10-10-2025 | ₹485.00 | ₹110 | ₹595 | 22.68% |
| 9-10-2025 | ₹485.00 | ₹111.00 | ₹596.00 | 22.89% |
| 8-10-2025 | ₹485.00 | ₹100.00 | ₹585.00 | 20.62% |
| 7-10-2025 | ₹485.00 | ₹98.00 | ₹538.00 | 20.21% |
| 6-10-2025 | ₹485.00 | ₹80.00 | ₹565.00 | 16.49% |
| 5-10-2025 | ₹485.00 | ₹80.00 | ₹565.00 | 16.49% |
| 4-10-2025 | ₹485.00 | ₹60.00 | ₹553.00 | 14.02% |
| 3-10-2025 | ₹485.00 | ₹60.00 | ₹553.00 | 14.02% |
| 2-10-2025 | ₹485.00 | ₹0.00 | ₹485.00 | 0.00% |
| 1-10-2025 | ₹485.00 | ₹0.00 | ₹485.00 | 0.00% |
As of 14th October 2025, the Rubicon Research IPO GMP stands at ₹130 per share. This means the share will likely list at ₹615 on its tentative Listing date, 16th October 2025. GMP data is subject to change based on market conditions. Please verify the live GMP status before applying for the Rubicon Research IPO GMP. Stay informed with Univest for real-time updates on IPOs and their GMP trends.
About Rubicon Research Limited
Rubicon Research Limited, established in 1999, is a pharmaceutical company engaged in the development, manufacturing, and commercialisation of differentiated formulations. As of June 30, 2025, Rubicon Research had a portfolio of 72 active Abbreviated New Drug Application (ANDA) and New Drug Application (NDA) products approved by the US FDA. The company’s portfolio includes 66 commercialised products, with a US generic pharmaceutical market size of USD 2,455.7 million, of which Rubicon Research Limited contributed USD 195 million in Fiscal 2024. As of June 30, 2025, the company has 17 new products awaiting US FDA ANDA approval and 63 products at various stages of development. As of June 30, 2025, the company marketed over 350 SKUs to 96 customers, including three major wholesalers who account for more than 90% of wholesale drug distribution in the US. The company also supplies group purchasing organisations (GPOs), national pharmacy chains, regional pharmacy chains, and managed care organisations.
Rubicon Research Limited Financials
The company’s financial analysis is essential before applying for the Rubicon Research IPO. Refer to the table to learn about Rubicon Research Limited’s financial information.
| Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 1,451.43 | 1,109.49 | 749.70 |
| Revenue | 1,296.22 | 872.39 | 419.00 |
| Profit After Tax | 134.36 | 91.01 | -16.89 |
| Net Worth | 540.98 | 385.00 | 286.38 |
| EBITDA | 267.89 | 173.09 | 43.97 |
| Reserve and Surplus | 525.57 | 369.79 | 281.31 |
| Total Borrowing | 393.17 | 396.41 | 317.91 |
Explanation
Rubicon Research Limited’s revenue increased by 49% from ₹872.39 crore in March 2024 to ₹1,296.22 crore in March 2025. Moreover, the company’s PAT rose by 48% from ₹91.01 crores to ₹134.36 crores.
How to Check Rubicon Research IPO Allotment Status?
You can check whether the Rubicon Research IPO allotment has been completed in various ways. These include NSE and the registrar portal. Refer to the steps below to check your allotment status online.
Check On BSE
- Visit the BSE Official Website.
- Navigate to the IPO Allotment Section.
- Select Equity as the issue type.
- Choose the Rubicon Research IPO.
- Choose whether to proceed with the PAN number or the application number.
- Submit your details to get the allotment status online.
Check On the Registrar Portal
- Visit the registrar portal.
- Click on the allotment option.
- Fill in the required details.
- Click on the submit button to know your Rubicon Research IPO allotment status.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Galaxy Medicare IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Accelerator IPO GMP & Review: Apply or Avoid?
Sharvaya Metals India IPO Listing Preview: What to Expect Now?